What laboratory tests should be ordered for a patient presenting with melena?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Laboratory Tests for Melena

Order a complete blood count (CBC) with hemoglobin/hematocrit, blood urea nitrogen (BUN), creatinine, and coagulation studies (PT/INR) immediately for any patient presenting with melena. 1

Essential Laboratory Panel

The international consensus guidelines for nonvariceal upper gastrointestinal bleeding specifically identify the critical laboratory tests needed for risk stratification and management decisions 1:

Primary Labs (Order Immediately):

  • Hemoglobin level - Essential for both the Blatchford and Rockall risk scores; determines transfusion threshold (transfuse if ≤70 g/L) 1
  • Blood urea nitrogen (BUN) - Core component of the Blatchford score for risk stratification 1
  • Creatinine - Elevated levels predict increased mortality risk 1
  • Coagulation studies (PT/INR) - Critical if patient is on anticoagulation (warfarin users are at higher risk) 2

Secondary Labs (Important for Complete Assessment):

  • Serum aminotransferase levels - Elevated levels associated with increased mortality 1
  • Type and crossmatch - Prepare for potential transfusion needs
  • Platelet count - Part of complete blood count, assesses bleeding risk

Clinical Context and Risk Stratification

These laboratory values directly feed into validated prognostic scoring systems that guide management intensity 1:

The Blatchford Score uses hemoglobin, BUN, pulse, and blood pressure to identify patients who need intervention versus those safe for outpatient management. This score accurately identifies low-risk patients who may not require urgent endoscopy 1.

The Rockall Score incorporates hemoglobin along with clinical parameters to predict rebleeding and mortality risk, with better discriminative ability for mortality than rebleeding 1.

Important Clinical Pearls

  • Hemoglobin nadir matters: Patients with melena who have hemoglobin ≤3 g/dL below normal limits are more likely to have identifiable bleeding sources on endoscopy 3
  • BUN elevation is significant: The BUN-to-creatinine ratio may be disproportionately elevated in upper GI bleeding due to blood protein absorption
  • Severe anemia warrants urgency: Cases with hemoglobin as low as 4-5 g/dL have been reported with small bowel sources 4, 5

Common Pitfalls to Avoid

Do not delay laboratory testing to pursue imaging first. The hemoglobin level directly determines transfusion decisions (threshold 70 g/L), and the combination of labs enables immediate risk stratification that guides the urgency and location of care 1. Patients with low initial hemoglobin levels have significantly increased risk for adverse outcomes 1.

While rare causes of melena exist (metastatic cancer 6, small bowel tumors 4), the standard laboratory workup remains the same and enables appropriate triage for endoscopic evaluation.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.